T1	B-Protein	0	4	CD14	CD14	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	4	5	-	-	O	HYPH	O	1	P	O
O	O	5	13	mediated	mediate	B-VP	VBN	O	4	NMOD	O
O	O	14	27	translocation	translocation	B-NP	NN	O	14	SUB	O
O	O	28	30	of	of	B-PP	IN	O	4	NMOD	O
T14	B-Entity	31	38	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
T14	I-Entity	39	45	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T14	I-Entity	45	46	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T14	I-Entity	46	51	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T14	I-Entity	52	53	B	B	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	54	61	induced	induce	B-VP	VBN	O	10	NMOD	O
O	O	62	64	by	by	B-PP	IN	O	11	VMOD	O
O	O	65	83	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	12	PMOD	O
O	O	84	88	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	89	92	not	not	I-VP	RB	O	14	VMOD	O
O	O	93	100	require	require	I-VP	VB	O	14	VC	O
T15	B-Entity	101	109	tyrosine	tyrosine	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	110	116	kinase	kinase	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	117	125	activity	activity	I-NP	NN	O	16	OBJ	O
O	O	125	126	.	.	O	.	O	14	P	O

O	O	128	134	During	During	B-PP	IN	O	13	VMOD	O
O	O	135	138	the	the	B-NP	DT	O	3	NMOD	O
O	O	139	145	course	course	I-NP	NN	O	1	PMOD	O
O	O	146	148	of	of	B-PP	IN	O	3	NMOD	O
O	O	149	156	serious	serious	B-NP	JJ	O	6	AMOD	O
O	O	157	166	bacterial	bacterial	I-NP	JJ	O	7	NMOD	O
O	O	167	177	infections	infection	I-NP	NNS	O	4	PMOD	O
O	O	177	178	,	,	O	,	O	13	P	O
O	O	179	197	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	13	SUB	O
O	O	198	199	(	(	O	(	O	12	DEP	O
O	O	199	202	LPS	LPS	B-NP	NN	O	12	DEP	O
O	O	202	203	)	)	O	)	O	9	NMOD	O
O	O	204	206	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	207	215	believed	believe	I-VP	VBN	O	13	VC	O
O	O	216	218	to	to	I-VP	TO	O	16	VMOD	O
O	O	219	227	interact	interact	I-VP	VB	O	14	VMOD	O
O	O	228	232	with	with	B-PP	IN	O	16	VMOD	O
O	O	233	243	macrophage	macrophage	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	244	253	receptors	receptor	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	253	254	,	,	O	,	O	16	P	O
O	O	255	264	resulting	result	B-VP	VBG	O	16	VMOD	O
O	O	265	267	in	in	B-PP	IN	O	21	VMOD	O
O	O	268	271	the	the	B-NP	DT	O	24	NMOD	O
O	O	272	282	generation	generation	I-NP	NN	O	30	NMOD	O
O	O	283	285	of	of	B-PP	IN	O	24	NMOD	O
O	O	286	298	inflammatory	inflammatory	B-NP	JJ	B-protein	27	NMOD	B-protein
O	O	299	308	mediators	mediator	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	309	312	and	and	O	CC	O	30	NMOD	O
O	O	313	321	systemic	systemic	B-NP	JJ	O	30	NMOD	O
O	O	322	330	symptoms	symptom	I-NP	NNS	O	22	PMOD	O
O	O	331	340	including	include	B-PP	VBG	O	30	NMOD	O
O	O	341	352	hemodynamic	hemodynamic	B-NP	JJ	O	35	NMOD	O
O	O	353	364	instability	instability	I-NP	NN	O	35	NMOD	O
O	O	365	368	and	and	I-NP	CC	O	35	NMOD	O
O	O	369	374	shock	shock	I-NP	NN	O	31	PMOD	O
O	O	374	375	.	.	O	.	O	13	P	O

T2	B-Protein	376	380	CD14	CD14	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	380	381	,	,	O	,	O	7	P	O
O	O	382	383	a	a	B-NP	DT	O	7	NMOD	O
O	O	384	412	glycosylphosphatidylinositol	glycosylphosphatidylinositol	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	412	413	-	-	O	HYPH	I-protein	7	NMOD	I-protein
O	O	413	419	linked	link	B-NP	VBN	I-protein	7	NMOD	I-protein
O	O	420	427	antigen	antigen	I-NP	NN	I-protein	9	SUB	I-protein
O	O	427	428	,	,	O	,	O	7	P	O
O	O	429	438	functions	function	B-VP	VBZ	O	0	ROOT	O
O	O	439	441	as	as	B-PP	IN	O	9	VMOD	O
O	O	442	444	an	an	B-NP	DT	O	14	NMOD	O
O	O	445	448	LPS	LPS	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	449	458	signaling	signaling	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	459	467	receptor	receptor	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	467	468	.	.	O	.	O	9	P	O

O	O	469	470	A	A	B-NP	DT	O	3	NMOD	O
O	O	471	479	critical	critical	I-NP	JJ	O	3	NMOD	O
O	O	480	485	issue	issue	I-NP	NN	O	4	SUB	O
O	O	486	494	concerns	concern	B-VP	VBZ	O	0	ROOT	O
O	O	495	498	the	the	B-NP	DT	O	6	NMOD	O
O	O	499	508	mechanism	mechanism	I-NP	NN	O	4	OBJ	O
O	O	509	511	by	by	B-PP	IN	O	6	NMOD	O
O	O	512	517	which	which	B-NP	WDT	O	7	PMOD	O
T3	B-Protein	518	522	CD14	CD14	B-NP	NN	B-protein	17	SUB	B-protein
O	O	522	523	,	,	O	,	O	9	P	O
O	O	524	529	which	which	B-NP	WDT	O	9	NMOD	O
O	O	530	533	has	have	B-VP	VBZ	O	11	SBAR	O
O	O	534	536	no	no	B-NP	DT	O	15	NMOD	O
T16	B-Entity	537	550	transmembrane	transmembrane	I-NP	JJ	B-protein	15	NMOD	B-protein
T16	I-Entity	551	557	domain	domain	I-NP	NN	I-protein	12	OBJ	I-protein
O	O	557	558	,	,	O	,	O	9	P	O
O	O	559	569	transduces	transduce	B-VP	VBZ	O	7	SBAR	O
O	O	570	573	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	574	580	signal	signal	I-NP	NN	O	17	OBJ	O
O	O	581	590	following	follow	B-PP	VBG	O	17	VMOD	O
O	O	591	594	LPS	LPS	B-NP	NN	O	22	NMOD	O
O	O	595	602	binding	binding	I-NP	NN	O	20	PMOD	O
O	O	602	603	.	.	O	.	O	4	P	O

O	O	604	612	Recently	Recently	B-ADVP	RB	O	4	VMOD	O
O	O	612	613	,	,	O	,	O	4	P	O
O	O	614	627	investigators	investigator	B-NP	NNS	O	4	SUB	O
O	O	628	632	have	have	B-VP	VBP	O	0	ROOT	O
O	O	633	645	hypothesized	hypothesize	I-VP	VBN	O	4	VC	O
O	O	646	650	that	that	B-SBAR	IN	O	5	VMOD	O
T4	B-Protein	651	655	CD14	CD14	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	655	656	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	656	664	mediated	mediate	I-NP	VBN	O	10	NMOD	O
O	O	665	674	signaling	signaling	I-NP	NN	O	11	SUB	O
O	O	675	677	is	be	B-VP	VBZ	O	6	SBAR	O
O	O	678	686	effected	effect	I-VP	VBN	O	11	VC	O
O	O	687	694	through	through	B-PP	IN	O	12	VMOD	O
O	O	695	696	a	a	B-NP	DT	O	19	NMOD	O
O	O	697	705	receptor	receptor	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	705	706	-	-	O	HYPH	I-protein	19	P	I-protein
O	O	706	716	associated	associate	B-NP	VBN	I-protein	19	NMOD	I-protein
T17	B-Entity	717	725	tyrosine	tyrosine	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	726	732	kinase	kinase	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	733	734	(	(	O	(	O	22	DEP	O
O	O	734	736	TK	TK	B-NP	NN	B-protein	22	DEP	B-protein
O	O	736	737	)	)	O	)	O	19	NMOD	O
O	O	737	738	,	,	O	,	O	11	P	O
O	O	739	749	suggesting	suggest	B-VP	VBG	O	11	VMOD	O
O	O	750	751	a	a	B-NP	DT	O	28	NMOD	O
O	O	752	766	multicomponent	multicomponent	I-NP	JJ	O	28	NMOD	O
O	O	767	775	receptor	receptor	I-NP	NN	O	28	NMOD	O
O	O	776	781	model	model	I-NP	NN	O	24	OBJ	O
O	O	782	784	of	of	B-PP	IN	O	28	NMOD	O
O	O	785	788	LPS	LPS	B-NP	NN	O	31	NMOD	O
O	O	789	798	signaling	signaling	I-NP	NN	O	29	PMOD	O
O	O	798	799	.	.	O	.	O	4	P	O

O	O	800	804	Wild	Wild	B-NP	JJ	O	6	NMOD	O
O	O	804	805	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	805	809	type	type	I-NP	NN	O	6	NMOD	O
O	O	810	817	Chinese	Chinese	I-NP	JJ	O	6	NMOD	O
O	O	818	825	hamster	hamster	I-NP	NN	O	6	NMOD	O
O	O	826	831	ovary	ovary	I-NP	NN	O	12	NMOD	O
O	O	832	833	(	(	O	(	O	9	DEP	O
O	O	833	836	CHO	CHO	B-NP	NN	O	9	DEP	O
O	O	836	837	)	)	O	)	O	6	NMOD	O
O	O	837	838	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	838	840	K1	K1	I-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	841	846	cells	cell	I-NP	NNS	I-cell_line	13	SUB	I-cell_line
O	O	847	850	can	can	B-VP	MD	O	0	ROOT	O
O	O	851	853	be	be	I-VP	VB	O	13	VC	O
O	O	854	863	activated	activate	I-VP	VBN	O	14	VC	O
O	O	864	866	by	by	B-PP	IN	O	15	VMOD	O
O	O	867	876	endotoxin	endotoxin	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	877	879	to	to	B-VP	TO	O	19	VMOD	O
O	O	880	887	release	release	I-VP	VB	O	13	VMOD	O
O	O	888	900	arachidonate	arachidonate	B-NP	NN	O	19	OBJ	O
O	O	901	910	following	follow	B-PP	VBG	O	19	VMOD	O
O	O	911	923	transfection	transfection	B-NP	NN	O	21	PMOD	O
O	O	924	928	with	with	B-PP	IN	O	22	NMOD	O
O	O	929	934	human	human	B-NP	JJ	B-protein	25	NMOD	B-protein
T5	B-Protein	935	939	CD14	CD14	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	940	941	(	(	O	(	O	30	DEP	O
O	O	941	944	CHO	CHO	B-NP	NN	O	29	NMOD	O
O	O	944	945	/	/	O	SYM	O	29	P	O
T6	B-Protein	945	949	CD14	CD14	B-NP	NN	B-protein	30	DEP	B-protein
O	O	949	950	)	)	O	)	O	25	NMOD	O
O	O	950	951	.	.	O	.	O	13	P	O

O	O	952	959	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	960	973	translocation	translocation	I-NP	NN	O	9	SUB	O
O	O	974	976	of	of	B-PP	IN	O	2	NMOD	O
O	O	977	986	cytosolic	cytosolic	B-NP	JJ	B-protein	8	NMOD	B-protein
T18	B-Entity	987	989	NF	NF	I-NP	NN	I-protein	8	NMOD	I-protein
T18	I-Entity	989	990	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T18	I-Entity	990	995	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T18	I-Entity	996	997	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	998	1000	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1001	1011	correlated	correlate	I-VP	VBN	O	9	VC	O
O	O	1012	1016	with	with	B-PP	IN	O	10	VMOD	O
O	O	1017	1018	a	a	B-NP	DT	O	13	NMOD	O
O	O	1019	1025	number	number	I-NP	NN	O	11	PMOD	O
O	O	1026	1028	of	of	B-PP	IN	O	13	NMOD	O
O	O	1029	1032	LPS	LPS	B-NP	NN	O	18	NMOD	O
O	O	1032	1033	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	1033	1042	inducible	inducible	I-NP	JJ	O	18	NMOD	O
O	O	1043	1052	responses	response	I-NP	NNS	O	14	PMOD	O
O	O	1052	1053	.	.	O	.	O	9	P	O

O	O	1054	1056	We	We	B-NP	PRP	O	2	SUB	O
O	O	1057	1063	sought	seek	B-VP	VBD	O	0	ROOT	O
O	O	1064	1066	to	to	I-VP	TO	O	4	VMOD	O
O	O	1067	1076	determine	determine	I-VP	VB	O	2	VMOD	O
O	O	1077	1079	if	if	B-SBAR	IN	O	4	VMOD	O
O	O	1080	1084	this	this	B-NP	DT	O	7	NMOD	O
O	O	1085	1092	pathway	pathway	I-NP	NN	O	8	SUB	O
O	O	1093	1097	were	be	B-VP	VBD	O	5	SBAR	O
O	O	1098	1105	present	present	B-ADJP	JJ	O	8	PRD	O
O	O	1106	1108	in	in	B-PP	IN	O	9	AMOD	O
O	O	1109	1112	CHO	CHO	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	1112	1113	/	/	B-NP	SYM	I-cell_line	14	NMOD	I-cell_line
T7	B-Protein	1113	1117	CD14	CD14	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	1118	1123	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1124	1127	and	and	O	CC	O	4	VMOD	O
O	O	1128	1130	to	to	B-VP	TO	O	17	VMOD	O
O	O	1131	1140	elucidate	elucidate	I-VP	VB	O	4	VMOD	O
O	O	1141	1144	the	the	B-NP	DT	O	19	NMOD	O
O	O	1145	1157	relationship	relationship	I-NP	NN	O	17	OBJ	O
O	O	1158	1160	of	of	B-PP	IN	O	19	NMOD	O
T19	B-Entity	1161	1163	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T19	I-Entity	1163	1164	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T19	I-Entity	1164	1169	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T19	I-Entity	1170	1171	B	B	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	1172	1182	activation	activation	I-NP	NN	O	20	PMOD	O
O	O	1183	1185	to	to	B-PP	TO	O	19	NMOD	O
O	O	1186	1189	the	the	B-NP	DT	O	30	NMOD	O
T8	B-Protein	1190	1194	CD14	CD14	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	1195	1203	receptor	receptor	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	1204	1210	system	system	I-NP	NN	O	26	PMOD	O
O	O	1210	1211	.	.	O	.	O	2	P	O

O	O	1212	1215	LPS	LPS	B-NP	NN	O	15	SUB	O
O	O	1215	1216	-	-	B-PP	HYPH	O	1	NMOD	O
O	O	1216	1226	stimulated	stimulate	B-NP	VBN	O	4	NMOD	O
O	O	1227	1240	translocation	translocation	I-NP	NN	O	2	PMOD	O
O	O	1241	1243	of	of	B-PP	IN	O	4	NMOD	O
T20	B-Entity	1244	1246	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T20	I-Entity	1246	1247	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T20	I-Entity	1247	1252	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T20	I-Entity	1253	1254	B	B	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	1255	1257	in	in	B-PP	IN	O	4	NMOD	O
O	O	1258	1261	CHO	CHO	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	1261	1262	/	/	B-NP	SYM	I-cell_line	14	NMOD	I-cell_line
T9	B-Protein	1262	1266	CD14	CD14	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	1267	1272	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1273	1282	resembled	resemble	B-VP	VBD	O	0	ROOT	O
O	O	1283	1286	the	the	B-NP	DT	O	18	NMOD	O
O	O	1287	1291	same	same	I-NP	JJ	O	18	NMOD	O
O	O	1292	1300	response	response	I-NP	NN	O	15	OBJ	O
O	O	1301	1303	in	in	B-PP	IN	O	18	NMOD	O
O	O	1304	1307	the	the	B-NP	DT	O	30	NMOD	O
O	O	1308	1314	murine	murine	I-NP	JJ	B-cell_line	22	NMOD	B-cell_line
O	O	1315	1325	macrophage	macrophage	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	1325	1326	-	-	B-NP	HYPH	I-cell_line	26	NMOD	I-cell_line
O	O	1326	1330	like	like	I-NP	JJ	I-cell_line	26	NMOD	I-cell_line
O	O	1331	1335	cell	cell	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	1336	1340	line	line	I-NP	NN	I-cell_line	30	NMOD	I-cell_line
O	O	1341	1344	RAW	RAW	I-NP	NN	B-cell_line	30	NMOD	B-cell_line
O	O	1345	1348	264	264	I-NP	CD	I-cell_line	30	NMOD	I-cell_line
O	O	1348	1349	.	.	I-NP	.	I-cell_line	30	NMOD	I-cell_line
O	O	1349	1350	7	7	I-NP	CD	I-cell_line	19	PMOD	I-cell_line
O	O	1350	1351	.	.	O	.	O	15	P	O

O	O	1352	1359	Protein	Protein	B-NP	NN	O	3	NMOD	O
O	O	1360	1369	synthesis	synthesis	I-NP	NN	O	3	NMOD	O
O	O	1370	1380	inhibitors	inhibitor	I-NP	NNS	O	5	NMOD	O
O	O	1381	1384	and	and	I-NP	CC	O	5	NMOD	O
O	O	1385	1400	corticosteroids	corticosteroid	I-NP	NNS	O	18	SUB	O
O	O	1400	1401	,	,	O	,	O	5	P	O
O	O	1402	1407	which	which	B-NP	WDT	O	5	NMOD	O
O	O	1408	1416	suppress	suppress	B-VP	VBP	O	7	SBAR	O
O	O	1417	1429	arachidonate	arachidonate	B-NP	NN	O	10	NMOD	O
O	O	1430	1437	release	release	I-NP	NN	O	13	NMOD	O
O	O	1438	1441	and	and	O	CC	O	13	NMOD	O
O	O	1442	1445	the	the	B-NP	DT	O	13	NMOD	O
O	O	1446	1455	synthesis	synthesis	I-NP	NN	O	8	OBJ	O
O	O	1456	1458	of	of	B-PP	IN	O	13	NMOD	O
O	O	1459	1474	proinflammatory	proinflammatory	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	1475	1484	cytokines	cytokine	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	1484	1485	,	,	O	,	O	5	P	O
O	O	1486	1489	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1490	1492	no	no	B-NP	DT	O	20	NMOD	O
O	O	1493	1499	effect	effect	I-NP	NN	O	18	OBJ	O
O	O	1500	1502	on	on	B-PP	IN	O	18	VMOD	O
O	O	1503	1516	translocation	translocation	B-NP	NN	O	21	PMOD	O
O	O	1517	1519	of	of	B-PP	IN	O	22	NMOD	O
T21	B-Entity	1520	1522	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T21	I-Entity	1522	1523	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T21	I-Entity	1523	1528	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T21	I-Entity	1529	1530	B	B	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	1531	1533	in	in	B-PP	IN	O	22	NMOD	O
O	O	1534	1537	CHO	CHO	B-NP	NN	B-protein	37	NMOD	B-protein
O	O	1537	1538	/	/	B-VP	SYM	O	37	P	O
T10	B-Protein	1538	1542	CD14	CD14	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	1543	1545	or	or	O	CC	O	33	NMOD	O
O	O	1546	1549	RAW	RAW	B-NP	NN	B-cell_line	37	NMOD	B-cell_line
O	O	1550	1553	264	264	I-NP	CD	I-cell_line	33	NMOD	I-cell_line
O	O	1553	1554	.	.	O	.	I-cell_line	37	NMOD	I-cell_line
O	O	1554	1555	7	7	B-NP	CD	I-cell_line	37	NMOD	I-cell_line
O	O	1556	1561	cells	cell	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	1561	1562	,	,	O	,	O	18	P	O
O	O	1563	1576	demonstrating	demonstrate	B-VP	VBG	O	18	VMOD	O
O	O	1577	1581	that	that	B-SBAR	IN	O	39	VMOD	O
T22	B-Entity	1582	1584	NF	NF	B-NP	NN	B-protein	45	NMOD	B-protein
T22	I-Entity	1584	1585	-	-	B-NP	HYPH	I-protein	45	NMOD	I-protein
T22	I-Entity	1585	1590	kappa	kappa	I-NP	NN	I-protein	45	NMOD	I-protein
T22	I-Entity	1591	1592	B	B	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	1593	1606	translocation	translocation	I-NP	NN	O	46	SUB	O
O	O	1607	1609	is	be	B-VP	VBZ	O	40	SBAR	O
O	O	1610	1612	an	an	B-NP	DT	O	49	NMOD	O
O	O	1613	1618	early	early	I-NP	JJ	O	49	NMOD	O
O	O	1619	1624	event	event	I-NP	NN	O	46	PRD	O
O	O	1624	1625	.	.	O	.	O	18	P	O

O	O	1626	1634	Although	Although	B-SBAR	IN	O	23	VMOD	O
O	O	1635	1637	TK	TK	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	1638	1646	activity	activity	I-NP	NN	O	4	SUB	O
O	O	1647	1650	was	be	B-VP	VBD	O	1	SBAR	O
O	O	1651	1663	consistently	consistently	I-VP	RB	O	4	VMOD	O
O	O	1664	1672	observed	observe	I-VP	VBN	O	4	VC	O
O	O	1673	1675	by	by	B-PP	IN	O	6	VMOD	O
O	O	1676	1690	immunoblotting	immunoblotte	B-VP	VBG	O	9	NMOD	O
O	O	1691	1699	extracts	extract	B-NP	NNS	O	7	PMOD	O
O	O	1700	1704	from	from	B-PP	IN	O	9	NMOD	O
O	O	1705	1714	activated	activate	B-NP	VBN	O	16	NMOD	O
O	O	1715	1718	RAW	RAW	I-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	1719	1722	264	264	I-NP	CD	I-cell_line	16	NMOD	I-cell_line
O	O	1722	1723	.	.	O	.	I-cell_line	16	NMOD	I-cell_line
O	O	1723	1724	7	7	B-NP	CD	I-cell_line	16	NMOD	I-cell_line
O	O	1725	1730	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1730	1731	,	,	O	,	O	23	P	O
O	O	1732	1735	LPS	LPS	B-NP	NN	O	22	NMOD	O
O	O	1735	1736	-	-	B-VP	HYPH	O	22	P	O
O	O	1736	1743	induced	induce	B-NP	VBN	O	22	NMOD	O
T23	B-Entity	1744	1759	phosphotyrosine	phosphotyrosine	I-NP	NN	O	22	NMOD	O
T23	I-Entity	1760	1768	residues	residue	I-NP	NNS	O	23	SUB	O
O	O	1769	1773	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1774	1777	not	not	I-VP	RB	O	23	VMOD	O
O	O	1778	1786	observed	observe	I-VP	VBN	O	23	VC	O
O	O	1787	1791	from	from	B-PP	IN	O	25	VMOD	O
O	O	1792	1801	similarly	similarly	B-NP	RB	O	28	AMOD	O
O	O	1802	1809	treated	treat	I-NP	VBN	O	32	NMOD	O
O	O	1810	1813	CHO	CHO	I-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	1813	1814	/	/	B-NP	SYM	I-cell_line	32	NMOD	I-cell_line
T11	B-Protein	1814	1818	CD14	CD14	B-NP	NN	I-cell_line	32	NMOD	I-cell_line
O	O	1819	1824	cells	cell	I-NP	NNS	I-cell_line	26	PMOD	I-cell_line
O	O	1824	1825	.	.	O	.	O	23	P	O

O	O	1826	1837	Furthermore	Furthermore	B-ADVP	RB	O	10	VMOD	O
O	O	1837	1838	,	,	O	,	O	10	P	O
O	O	1839	1842	the	the	B-NP	DT	O	5	NMOD	O
O	O	1843	1845	TK	TK	I-NP	NN	O	5	NMOD	O
O	O	1846	1856	inhibitors	inhibitor	I-NP	NNS	O	9	NMOD	O
O	O	1857	1867	herbimycin	herbimycin	I-NP	NN	O	7	NMOD	O
O	O	1868	1869	A	A	I-NP	NN	O	9	NMOD	O
O	O	1870	1873	and	and	O	CC	O	9	NMOD	O
O	O	1874	1883	genistein	genistein	B-NP	NN	O	10	SUB	O
O	O	1884	1890	failed	fail	B-VP	VBD	O	0	ROOT	O
O	O	1891	1893	to	to	I-VP	TO	O	12	VMOD	O
O	O	1894	1901	inhibit	inhibit	I-VP	VB	O	10	VMOD	O
O	O	1902	1915	translocation	translocation	B-NP	NN	O	12	OBJ	O
O	O	1916	1918	of	of	B-PP	IN	O	13	NMOD	O
T24	B-Entity	1919	1921	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T24	I-Entity	1921	1922	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T24	I-Entity	1922	1927	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T24	I-Entity	1928	1929	B	B	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	1930	1932	in	in	B-PP	IN	O	13	NMOD	O
O	O	1933	1936	CHO	CHO	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	1936	1937	/	/	B-VP	SYM	O	28	P	O
T12	B-Protein	1937	1941	CD14	CD14	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	1942	1944	or	or	O	CC	O	24	NMOD	O
O	O	1945	1948	RAW	RAW	B-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	1949	1952	264	264	I-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	1952	1953	.	.	O	.	I-cell_line	28	NMOD	I-cell_line
O	O	1953	1954	7	7	B-NP	CD	I-cell_line	28	NMOD	I-cell_line
O	O	1955	1960	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	1960	1961	,	,	O	,	O	10	P	O
O	O	1962	1970	although	although	B-SBAR	IN	O	10	VMOD	O
O	O	1971	1975	both	both	B-NP	DT	O	35	SUB	O
O	O	1976	1978	of	of	B-PP	IN	O	31	NMOD	O
O	O	1979	1984	these	these	B-NP	DT	O	34	NMOD	O
O	O	1985	1991	agents	agent	I-NP	NNS	O	32	PMOD	O
O	O	1992	2001	inhibited	inhibit	B-VP	VBD	O	30	SBAR	O
O	O	2002	2005	LPS	LPS	B-NP	NN	O	40	NMOD	O
O	O	2005	2006	-	-	B-NP	HYPH	O	36	P	O
O	O	2006	2013	induced	induce	I-NP	VBN	O	40	NMOD	O
O	O	2014	2016	TK	TK	I-NP	NN	B-protein	40	NMOD	B-protein
O	O	2017	2025	activity	activity	I-NP	NN	O	35	OBJ	O
O	O	2026	2028	in	in	B-PP	IN	O	35	VMOD	O
O	O	2029	2032	RAW	RAW	B-NP	NN	B-cell_line	41	PMOD	B-cell_line
O	O	2033	2036	264	264	I-NP	CD	I-cell_line	42	NMOD	I-cell_line
O	O	2036	2037	.	.	O	.	I-cell_line	10	P	I-cell_line
O	O	2037	2038	7	7	B-NP	CD	I-cell_line	46	NMOD	I-cell_line
O	O	2039	2044	cells	cell	I-NP	NNS	I-cell_line	10	VMOD	I-cell_line
O	O	2044	2045	.	.	O	.	O	10	P	O

O	O	2046	2051	These	These	B-NP	DT	O	2	NMOD	O
O	O	2052	2059	results	result	I-NP	NNS	O	3	SUB	O
O	O	2060	2065	imply	imply	B-VP	VBP	O	0	ROOT	O
O	O	2066	2070	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	2071	2073	TK	TK	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	2074	2082	activity	activity	I-NP	NN	O	7	SUB	O
O	O	2083	2085	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	2086	2089	not	not	O	RB	O	7	VMOD	O
O	O	2090	2100	obligatory	obligatory	B-ADJP	JJ	O	7	PRD	O
O	O	2101	2104	for	for	B-PP	IN	O	9	AMOD	O
T13	B-Protein	2105	2109	CD14	CD14	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	2109	2110	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	2110	2118	mediated	mediate	I-NP	VBN	O	15	NMOD	O
O	O	2119	2125	signal	signal	I-NP	NN	O	15	NMOD	O
O	O	2126	2138	transduction	transduction	I-NP	NN	O	17	SUB	O
O	O	2139	2141	to	to	B-VP	TO	O	17	VMOD	O
O	O	2142	2147	occur	occur	I-VP	VB	O	10	SBAR	O
O	O	2148	2150	in	in	B-PP	IN	O	17	VMOD	O
O	O	2151	2159	response	response	B-NP	NN	O	18	PMOD	O
O	O	2160	2162	to	to	B-PP	TO	O	19	NMOD	O
O	O	2163	2166	LPS	LPS	B-NP	NN	O	20	PMOD	O
O	O	2166	2167	.	.	O	.	O	3	P	O
